Comments

Harmony Biosciences

Q: What sector and industry does Harmony Biosciences (HRMY) operate in?

Harmony Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

HRMYNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$34.83

At close: Jan 2, 4:00 PM EDT

$34.83

0.000.00%

After Hours: 4:00 PM EDT

Harmony Biosciences (HRMY) Forecast

News Earnings Harmony Biosciences (HRMY) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Good

Technicals Analysis

0100

Financials Analysis

0100

Harmony Biosciences (NASDAQ:HRMY) Stock Quotes, Forecast and News Summary

Harmony Biosciences Stock (NASDAQ: HRMY) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 762.30K
Day Range	- - -
52 Wk Range	28.14 - 41.61
Market Cap	$1.99B
P/E Ratio	16.51
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	42.11%
Days to Cover	11.44

Recent News

Why Harmony Biosciences (HRMY) Stock Is Down 18% Today

Harmony Biosciences shares are trading lower by 17% Wednesday afternoon. The company announced a public offering of up to 8 million common stock shares from selling shareholders.

Henry Khederian

Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says

UBS has initiated coverage on Harmony Biosciences with a Buy rating and a price target of $56. UBS highlights Harmony's potential for growth, projecting a 19% CAGR for Wakix sales through 2026.

Vandana Singh

5 High Earnings Yield Value Stocks That You Shouldn't Ignore

After all major indexes ended the first half of the year in the green, more gains are anticipated in the second half. The resilient economy, robust job market, upward-trending sales and earnings estimates, and near-record household incomes provide strong support for continued market growth.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Oct 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 762.30K
Day Range	- - -
52 Wk Range	28.14 - 41.61
Market Cap	$1.99B
P/E Ratio	16.51
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	42.11%
Days to Cover	11.44

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Harmony Biosciences (HRMY) stock?

You can purchase shares of Harmony Biosciences (NASDAQ:HRMY) through any online brokerage.

View our list of the best stock brokerages

Who are Harmony Biosciences (HRMY) competitors?

Other companies in Harmony Biosciences’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and Neumora Therapeutics (NASDAQ:NMRA).

What is the forecast, or price target, for Harmony Biosciences (HRMY) stock?

Harmony Biosciences has a consensus price target of $50.77.

What is the current price for Harmony Biosciences (HRMY)?

The stock price for Harmony Biosciences (NASDAQ: HRMY) is $34.83 last updated January 2, 2025 at 4:00 PM EST.

Does Harmony Biosciences (HRMY) pay a dividend?

There are no upcoming dividends for Harmony Biosciences.

When is Harmony Biosciences (NASDAQ:HRMY) reporting earnings?

Harmony Biosciences’s Q4 earnings are confirmed for Thursday, February 20, 2025.

Is Harmony Biosciences (HRMY) going to split?

There is no upcoming split for Harmony Biosciences.

What sector and industry does Harmony Biosciences (HRMY) operate in?

Harmony Biosciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.